Slow release coating layer of degradable medication for bracket of coronary artery
A drug and sustained-release technology, which is applied in the field of medical materials to achieve good biocompatibility, prevent and inhibit restenosis of blood vessels, and prevent release.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0021] The drug uses rapamycin, the biodegradable polymer carrier is polylactic acid-glycolic acid (PLGA) polymer, the molar ratio n(dl-LA) / n(GA) is 85 / 15, and the molecular weight is 600000. The weight ratio of the pamycin to the polymer carrier is 1:6.
Embodiment 2
[0023] The drug uses rapamycin, the biodegradable polymer carrier is polylactic acid-glycolic acid (PLGA) polymer, the molar ratio n(dl-LA) / n(GA) is 90 / 10, the molecular weight is 45000, and the molecular weight is 45000. The weight ratio of the pamycin to the polymer carrier is 1:3.
Embodiment 3
[0025] The drug adopts paclitaxel, the biodegradable polymer carrier is polylactic acid-glycolic acid (PLGA) copolymer, the molar ratio n(dl-LA) / n(GA) is 50 / 50, the molecular weight is 75000, paclitaxel and polymer The weight ratio of the carrier is 1:10.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com